Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys plus Ribavirin in HCV patients intolerant or non-responsive to PEG-Intron
NCT00087568Phase 4Completed
- Sponsor
- Roche
- Start
- Jan 2003
- Primary completion
- Mar 2006
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of pegylated interferon alpha in hepatitis C (HCV), sponsored by Roche. Started Jan 2003; status: completed.
02
Drugs
pegylated interferon alpha
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00087568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00087568.